Logo image of MOH

MOLINA HEALTHCARE INC (MOH) Stock Fundamental Analysis

USA - NYSE:MOH - US60855R1005 - Common Stock

139.831 USD
+3.04 (+2.22%)
Last: 11/18/2025, 2:57:08 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MOH. MOH was compared to 100 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of MOH get a neutral evaluation. Nothing too spectacular is happening here. MOH has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

MOH had positive earnings in the past year.
MOH had a negative operating cash flow in the past year.
In the past 5 years MOH has always been profitable.
Each year in the past 5 years MOH had a positive operating cash flow.
MOH Yearly Net Income VS EBIT VS OCF VS FCFMOH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

1.2 Ratios

MOH has a better Return On Assets (5.62%) than 81.00% of its industry peers.
MOH has a better Return On Equity (21.07%) than 89.00% of its industry peers.
The Return On Invested Capital of MOH (11.98%) is better than 87.00% of its industry peers.
MOH had an Average Return On Invested Capital over the past 3 years of 17.96%. This is significantly above the industry average of 9.40%.
The last Return On Invested Capital (11.98%) for MOH is well below the 3 year average (17.96%), which needs to be investigated, but indicates that MOH had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.62%
ROE 21.07%
ROIC 11.98%
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
MOH Yearly ROA, ROE, ROICMOH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

MOH has a better Profit Margin (1.98%) than 61.00% of its industry peers.
MOH's Profit Margin has declined in the last couple of years.
The Operating Margin of MOH (2.97%) is comparable to the rest of the industry.
MOH's Operating Margin has declined in the last couple of years.
MOH has a worse Gross Margin (13.91%) than 68.00% of its industry peers.
In the last couple of years the Gross Margin of MOH has declined.
Industry RankSector Rank
OM 2.97%
PM (TTM) 1.98%
GM 13.91%
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
MOH Yearly Profit, Operating, Gross MarginsMOH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

5

2. Health

2.1 Basic Checks

MOH has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
MOH has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MOH has been reduced compared to 5 years ago.
MOH has a worse debt/assets ratio than last year.
MOH Yearly Shares OutstandingMOH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MOH Yearly Total Debt VS Total AssetsMOH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 4.23 indicates that MOH is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.23, MOH is in the better half of the industry, outperforming 77.00% of the companies in the same industry.
MOH has a Debt/Equity ratio of 0.92. This is a neutral value indicating MOH is somewhat dependend on debt financing.
MOH's Debt to Equity ratio of 0.92 is on the low side compared to the rest of the industry. MOH is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z 4.23
ROIC/WACC1.41
WACC8.49%
MOH Yearly LT Debt VS Equity VS FCFMOH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

MOH has a Current Ratio of 1.68. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
MOH's Current ratio of 1.68 is fine compared to the rest of the industry. MOH outperforms 63.00% of its industry peers.
A Quick Ratio of 1.68 indicates that MOH should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.68, MOH is doing good in the industry, outperforming 67.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.68
MOH Yearly Current Assets VS Current LiabilitesMOH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The earnings per share for MOH have decreased strongly by -16.06% in the last year.
Measured over the past years, MOH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.16% on average per year.
MOH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.65%.
MOH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.29% yearly.
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%

3.2 Future

Based on estimates for the next years, MOH will show a small growth in Earnings Per Share. The EPS will grow by 6.50% on average per year.
Based on estimates for the next years, MOH will show a small growth in Revenue. The Revenue will grow by 4.76% on average per year.
EPS Next Y-33.62%
EPS Next 2Y-19.59%
EPS Next 3Y-8.28%
EPS Next 5Y6.5%
Revenue Next Year10.91%
Revenue Next 2Y7.4%
Revenue Next 3Y7.22%
Revenue Next 5Y4.76%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MOH Yearly Revenue VS EstimatesMOH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
MOH Yearly EPS VS EstimatesMOH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.58, which indicates a rather cheap valuation of MOH.
Compared to the rest of the industry, the Price/Earnings ratio of MOH indicates a rather cheap valuation: MOH is cheaper than 95.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 25.56. MOH is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 9.55, the valuation of MOH can be described as reasonable.
Based on the Price/Forward Earnings ratio, MOH is valued cheaply inside the industry as 92.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of MOH to the average of the S&P500 Index (34.62), we can say MOH is valued rather cheaply.
Industry RankSector Rank
PE 7.58
Fwd PE 9.55
MOH Price Earnings VS Forward Price EarningsMOH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.92
MOH Per share dataMOH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

The decent profitability rating of MOH may justify a higher PE ratio.
A cheap valuation may be justified as MOH's earnings are expected to decrease with -8.28% in the coming years.
PEG (NY)N/A
PEG (5Y)0.54
EPS Next 2Y-19.59%
EPS Next 3Y-8.28%

0

5. Dividend

5.1 Amount

No dividends for MOH!.
Industry RankSector Rank
Dividend Yield N/A

MOLINA HEALTHCARE INC

NYSE:MOH (11/18/2025, 2:57:08 PM)

139.831

+3.04 (+2.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-22 2025-10-22/amc
Earnings (Next)02-03 2026-02-03/amc
Inst Owners99.99%
Inst Owner Change12.24%
Ins Owners1.26%
Ins Owner Change3.38%
Market Cap7.58B
Revenue(TTM)44.55B
Net Income(TTM)883.00M
Analysts65.83
Price Target190.57 (36.29%)
Short Float %5.87%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.8%
Min EPS beat(2)-53.34%
Max EPS beat(2)-6.27%
EPS beat(4)1
Avg EPS beat(4)-17.79%
Min EPS beat(4)-53.34%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-7.75%
EPS beat(12)8
Avg EPS beat(12)-3.04%
EPS beat(16)12
Avg EPS beat(16)-1.32%
Revenue beat(2)2
Avg Revenue beat(2)3.64%
Min Revenue beat(2)3.29%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)2.53%
Min Revenue beat(4)0.69%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)3.12%
Revenue beat(12)10
Avg Revenue beat(12)2.26%
Revenue beat(16)14
Avg Revenue beat(16)2.23%
PT rev (1m)-7.12%
PT rev (3m)-12.49%
EPS NQ rev (1m)-71.68%
EPS NQ rev (3m)-74.68%
EPS NY rev (1m)-20.21%
EPS NY rev (3m)-36.95%
Revenue NQ rev (1m)-1.33%
Revenue NQ rev (3m)-1.39%
Revenue NY rev (1m)0.84%
Revenue NY rev (3m)0.99%
Valuation
Industry RankSector Rank
PE 7.58
Fwd PE 9.55
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 1.81
P/tB 3.81
EV/EBITDA -0.92
EPS(TTM)18.45
EY13.19%
EPS(NY)14.65
Fwd EY10.47%
FCF(TTM)-10.59
FCFYN/A
OCF(TTM)-8.51
OCFYN/A
SpS821.96
BVpS77.32
TBVpS36.7
PEG (NY)N/A
PEG (5Y)0.54
Graham Number179.16
Profitability
Industry RankSector Rank
ROA 5.62%
ROE 21.07%
ROCE 16.11%
ROIC 11.98%
ROICexc N/A
ROICexgc N/A
OM 2.97%
PM (TTM) 1.98%
GM 13.91%
FCFM N/A
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)24.15%
ROCE(5y)23.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
F-Score4
Asset Turnover2.84
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA 2.53
Cap/Depr 56.78%
Cap/Sales 0.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1.68
Altman-Z 4.23
F-Score4
WACC8.49%
ROIC/WACC1.41
Cap/Depr(3y)51.53%
Cap/Depr(5y)59.49%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.29%
Profit Quality(3y)92.3%
Profit Quality(5y)171.56%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
EPS Next Y-33.62%
EPS Next 2Y-19.59%
EPS Next 3Y-8.28%
EPS Next 5Y6.5%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
Revenue Next Year10.91%
Revenue Next 2Y7.4%
Revenue Next 3Y7.22%
Revenue Next 5Y4.76%
EBIT growth 1Y-19.56%
EBIT growth 3Y15.28%
EBIT growth 5Y10.22%
EBIT Next Year-15.62%
EBIT Next 3Y-1.12%
EBIT Next 5YN/A
FCF growth 1Y-128.12%
FCF growth 3Y-35.66%
FCF growth 5Y7.61%
OCF growth 1Y-121.54%
OCF growth 3Y-32.77%
OCF growth 5Y8.21%

MOLINA HEALTHCARE INC / MOH FAQ

What is the fundamental rating for MOH stock?

ChartMill assigns a fundamental rating of 5 / 10 to MOH.


Can you provide the valuation status for MOLINA HEALTHCARE INC?

ChartMill assigns a valuation rating of 5 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Fairly Valued.


How profitable is MOLINA HEALTHCARE INC (MOH) stock?

MOLINA HEALTHCARE INC (MOH) has a profitability rating of 6 / 10.


What is the financial health of MOLINA HEALTHCARE INC (MOH) stock?

The financial health rating of MOLINA HEALTHCARE INC (MOH) is 5 / 10.


What is the earnings growth outlook for MOLINA HEALTHCARE INC?

The Earnings per Share (EPS) of MOLINA HEALTHCARE INC (MOH) is expected to decline by -33.62% in the next year.